Cosmos Health Inc. (COSM) Income Statement
COSM 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCOSM revenue and net income
Where COSM's revenue goes
2025Each bar shows an amount and its share of revenue. COSM kept −29.3% of revenue as net income.
COSM profit margins
COSM growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +19.9% | +9.0% | +3.3% | +61.7% |
| Gross profit | +83.1% | +9.8% | −0.4% | +66.2% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
COSM quarterly EPS vs estimates
Cosmos Health beat the analyst EPS estimate in 1 of the last 8 quarters. Next report: November 13, 2026 (estimate $-0.06).
COSM income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M | $39.7M | $37.1M | $30.0M | $6.8M |
| Cost of revenue | $57.4M | $50.1M | $49.0M | $44.4M | $47.9M | $47.3M | $36.0M | $34.7M | $28.1M | $6.2M |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M | $8.1M | $3.7M | $2.4M | $2.0M | $601,040 |
| Research & development | $519,363 | $533,293 | $164,859 | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $22.5M | $12.1M | $25.4M | $13.2M | $12.4M | $4.9M | $3.5M | $3.6M | $4.9M | $794,099 |
| Total operating expenses | $24.4M | $19.9M | $75.2M | $13.4M | $12.9M | $5.3M | $3.9M | $3.6M | $6.8M | $803,547 |
| Operating income | −$16.5M | −$15.5M | −$21.8M | −$7.5M | −$4.5M | $2.7M | −$255,809 | −$1.2M | −$4.9M | −$202,507 |
| Interest income | $396,413 | $406,449 | $662,859 | $236,349 | $46,316 | $65,865 | $0 | — | — | $0 |
| Interest expense | $2.6M | $1.0M | $866,476 | $4.0M | $3.6M | $2.8M | $1.7M | $6.8M | $1.6M | $206,014 |
| Income before taxes | −$19.1M | −$16.2M | −$18.5M | −$13.1M | −$7.8M | $1.2M | −$3.1M | −$9.0M | −$6.2M | −$600,233 |
| Income taxes | — | $6.2M | — | $775,051 | $114,010 | $377,535 | $182,815 | $17,326 | $2,801 | $769 |
| Net income | −$19.1M | −$16.2M | −$18.5M | −$13.8M | −$8.0M | $820,786 | −$3.3M | −$9.1M | −$6.2M | −$601,002 |
| EBITDA | −$15.2M | −$13.9M | −$17.1M | −$8.9M | −$4.1M | $4.4M | −$988,585 | −$2.2M | −$4.5M | −$384,769 |
| EPS (diluted) | −$1.29 | −$0.69 | −$9.57 | −$5.35 | −$13.59 | −$1.42 | −$0.81 | −$18.71 | −$6.59 | −$1.19 |
| Gross margin | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% | 14.5% | 9.2% | 6.5% | 6.5% | 8.9% |
| Operating margin | −25.3% | −28.6% | −40.9% | −14.8% | −8.1% | 4.9% | −0.6% | −3.3% | −16.2% | −3.0% |
| Net margin | −29.3% | −29.7% | −34.7% | −27.5% | −14.2% | 1.5% | −8.3% | −24.4% | −20.7% | −8.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.0M | $17.9M | $19.7M | $17.1M | $14.7M | $13.7M | $14.2M | $12.4M | $13.2M | $14.6M | $15.8M | $12.8M |
| Cost of revenue | $17.5M | $16.5M | $17.6M | $14.5M | $13.6M | $11.7M | $13.2M | $11.2M | $12.4M | $13.3M | $14.6M | $11.6M |
| Gross profit | $1.5M | $1.4M | $2.1M | $2.6M | $1.2M | $2.0M | $1.0M | $1.2M | $767,248 | $1.3M | $1.2M | $1.2M |
| Research & development | $68,552 | $410,760 | $410,760 | $18,337 | $74,637 | $15,629 | — | $0 | $0 | $0 | — | — |
| Sales, general & admin | $4.0M | $1.8M | $12.6M | $2.1M | $3.4M | $2.5M | $8.8M | $3.1M | $3.0M | $2.8M | $14.7M | $4.0M |
| Total operating expenses | $4.4M | $3.6M | $30.9M | $4.4M | $3.8M | $2.9M | $22.9M | $3.4M | $3.3M | $16.4M | $29.4M | $4.2M |
| Operating income | −$2.9M | −$2.2M | −$11.2M | −$1.8M | −$2.6M | −$833,145 | −$8.7M | −$2.2M | −$2.5M | −$1.8M | −$13.6M | −$3.0M |
| Interest income | $45,741 | $46,673 | $98,602 | $100,698 | $105,787 | $91,326 | $97,418 | $101,236 | $102,030 | $105,765 | $107,578 | $110,596 |
| Interest expense | $1.0M | $813,579 | $1.0M | $669,150 | $551,917 | $187,107 | $319,767 | $181,429 | $342,446 | $168,672 | $336,694 | $151,274 |
| Income before taxes | −$6.1M | −$2.8M | −$10.1M | −$5.4M | −$2.8M | −$818,097 | −$9.5M | −$2.2M | −$2.6M | −$1.9M | −$13.8M | −$3.4M |
| Income taxes | — | — | — | — | — | $6.2M | — | $6.2M | $360,496 | — | — | −$65,873 |
| Net income | −$6.1M | −$2.8M | −$10.1M | −$5.4M | −$2.8M | −$818,097 | −$9.5M | −$2.2M | −$2.6M | −$1.9M | −$13.8M | −$3.3M |
| EBITDA | −$4.7M | −$1.6M | −$8.8M | −$4.3M | −$1.9M | −$310,551 | — | −$1.7M | −$1.9M | — | — | −$3.0M |
| EPS (diluted) | −$0.03 | −$0.36 | −$0.36 | −$0.17 | −$0.06 | $0.01 | — | −$0.45 | −$0.15 | −$0.11 | −$1.70 | −$0.27 |
| Gross margin | 8.0% | 7.7% | 10.6% | 15.2% | 7.9% | 14.9% | 7.1% | 9.7% | 5.8% | 9.1% | 7.8% | 9.5% |
| Operating margin | −15.4% | −12.2% | −57.1% | −10.6% | −17.9% | −6.1% | −61.0% | −18.0% | −18.9% | −12.6% | −85.8% | −23.5% |
| Net margin | −32.1% | −15.6% | −51.5% | −31.3% | −19.2% | −6.0% | −67.1% | −17.6% | −19.6% | −12.8% | −86.8% | −26.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in COSM's financial statements (latest annual report filed April 15, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
COSM financial results
In fiscal year 2025 (ended December 31, 2025), Cosmos Health reported revenue of $65.3 million, up 19.9% from the year before. It had a net loss of $19.1 million, a net profit margin of −29.3%. Diluted earnings per share came to −$1.29. Over five years revenue grew at an average rate of 3.3% a year.
See the COSM stock overview for the latest quote and news, or the COSM chart for price history and technical indicators.
COSM income statement FAQ
What is Cosmos Health's annual revenue?
Cosmos Health reported total revenue of $65.3 million for fiscal year 2025, which ended on December 31, 2025. That was up 19.9% from $54.4 million the previous year.
Is Cosmos Health profitable?
No. Cosmos Health reported a net loss of $19.1 million in fiscal 2025, a net profit margin of −29.3%; its operating margin was −25.3%.
What is Cosmos Health's gross margin?
Cosmos Health's gross margin was 12.1% in fiscal 2025: for every $100 of revenue, Cosmos Health kept $12 after the direct cost of its products and services.
How much does Cosmos Health spend on research and development?
Cosmos Health spent $0.5 million on research and development in fiscal 2025, 0.8% of revenue.
How fast is Cosmos Health growing?
Revenue grew 3.3% a year on average over the last five fiscal years, from $55.4 million to $65.3 million.
What are Cosmos Health's earnings per share?
Cosmos Health earned $-1.29 per diluted share in fiscal 2025, compared with $-0.69 a year earlier.
When will Cosmos Health report its next earnings?
Cosmos Health is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
When does Cosmos Health's fiscal year end?
Cosmos Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 15, 2026.